{"id":4680,"date":"2025-03-31T18:12:16","date_gmt":"2025-03-31T18:12:16","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/sildenafil-txt\/"},"modified":"2025-03-31T18:12:16","modified_gmt":"2025-03-31T18:12:16","slug":"sildenafil-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/sildenafil-txt\/","title":{"rendered":"sildenafil.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3><br \/>\nTreatment of erectile dysfunction (ED) To increase exercise ability in pulmonary  arterial hypertension<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>ED: 25\u2013100 mg 0.5\u20134 hours before sexual  intercourse (ideally, about 1 hour); no more than 1 dose per dayPulmonary arterial hypertension: 20 mg 3  times daily<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :666.7 (as citrate)<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :96<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : &lt;2<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :1\u20132<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :4\/Increased<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4>30\u201350 Dose as in normal renal function10\u201330 Dose as in normal renal function ED: Initial dose 25 mg and increase if required<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Dose as in normal renal function ED: Initial dose 25 mg and increase if required<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Unlikely to be dialysed. Dose as in GFR &lt;10 mL\/min<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Unlikely to be dialysed. Dose as in GFR &lt;10 mL\/min<LI>HDF\/high flux  &amp;nbsp :Not dialysed. Dose as in GFR &lt;10 mL\/min<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Unlikely to be dialysed. Dose as in GFR 10 to 20   mL\/min <H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsAlpha-blockers: enhanced hypotensive  effect \u2013 avoid for 4 hours after sildenafil\n<li>Antivirals:  ritonavir significantly  increases sildenafil concentration \u2013 avoid concomitant use; concentration possibly increased by saquinavir, amprenavir, indinavir and nelfinavir \u2013 reduce dose of sildenafil; side effects possibly increased by atazanavirNicorandil: enhanced hypotensive effect \u2013  avoid concomitant use\n<li> Nitrates: enhanced hypotensive effect \u2013  absolutely contraindicated<H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>\u2013<H4>  Route  <\/H4>Oral <H4>  Rate of Administration  <\/H4>\u2013<H4>Comments<\/H4>\u2013<H4>  OTHER INFORMATION  <\/H4>Dialysis is not expected to increase  clearance as sildenafil is highly protein boundPatients should seek prompt medical  advice if their erections last for more than 4 hoursRecommend use on non-dialysis days due  to hypotension. In peritoneal dialysis, treatment with sildenafil is well toleratedAnecdotally it has been used at Guy\u2019s  hospital, London for diabetic gastroparesis at a dose of 25 mg 3 times a dayThe use of sildenafil is potentially  hazardous in patients with active coronary ischaemia, those with congestive heart failure, and those with complicated multi-drug antihypertensive therapy regimensIn 9 patients on maintenance  haemodialysis, sildenafil 50 mg appeared to produce firmer erections and greater sexual satisfaction, but the effects were prolonged for up to 48 hours after administration.<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Treatment of erectile dysfunction (ED) To increase exercise<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4680","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4680"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4680\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}